Advertisement
Screener

PRECIPIO, INC. (PRPO) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

3.0 / 5 stars · 43/71 Roast Me

PRECIPIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

PRECIPIO, INC. (PRPO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 1.56% for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2016-11-14

  • PRECIPIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2016-03-31 was 1.91%, a 18.63% increase year-over-year.
  • PRECIPIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2015-03-31 was 1.61%, a 6.40% decline year-over-year.
  • PRECIPIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2014-09-30 was 1.66%, a 19.42% increase year-over-year.
  • PRECIPIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2014-06-30 was 1.74%, a 117.50% increase year-over-year.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month
2016-09-301.56%
10-Q · filed 2016-11-14
2016-06-301.91%
10-Q · filed 2016-08-15
2016-03-311.91%
10-Q · filed 2016-05-23
2015-09-301.91%
10-Q · filed 2015-11-16
2015-06-301.32%
10-Q · filed 2015-08-14
2015-03-311.61%
10-Q · filed 2015-05-14
2014-09-301.66%
10-Q · filed 2014-11-12
2014-06-301.74%
10-Q · filed 2014-08-08
2014-03-311.72%
10-Q · filed 2014-05-15
2013-09-301.39%
10-Q · filed 2013-11-14
2013-06-300.80%
10-Q · filed 2013-08-08
2013-03-310.78%
10-Q · filed 2014-05-15
0.80%
10-Q · filed 2013-05-09
2012-09-300.70%
10-Q · filed 2013-11-14
0.70%
10-Q · filed 2012-11-08
2012-06-301.03%
10-Q · filed 2013-08-08
1.03%
10-Q · filed 2012-08-02
2012-03-310.80%
10-Q · filed 2013-05-09
2011-06-301.87%
10-Q · filed 2012-08-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15